Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2007
02/28/2007CN1922310A Methods for separating molecules
02/28/2007CN1922301A Enzyme stabilization in liquid detergents
02/28/2007CN1922198A Genetically modified yeast species and fermenation processes using genetically modified yeast
02/28/2007CN1921869A Lipase activity inhibitor containing high-molecular weight polyphenol fraction, tea extract and process for producing the same
02/28/2007CN1920048A Method for producing CMP-N-acetylneuraminic acid
02/28/2007CN1920044A O-acetylhomoserinesulfhydorelace gene and use thereof
02/28/2007CN1920043A Cysteine synthase gene and use thereof
02/28/2007CN1920042A Dunaliella salina discrepancy expressed label and gene fragment at low-salt and high-salt infiltration intimidation and clone method thereof
02/28/2007CN1920040A Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production
02/28/2007CN1920038A Transposon gene of rice
02/28/2007CN1920037A Transposon gene of rice
02/28/2007CN1920027A Human hPTP gene order, encode albumen and preparation method thereof
02/28/2007CN1920022A Human hMKPx gene order, encode albumen and preparation method thereof
02/28/2007CN1920017A Separating and purifying method of agkistrodonacutus thrombin
02/28/2007CN1920016A Preparation method of solid-state machinery fermentation xylanase
02/28/2007CN1920015A Recombination tyrosine kinase expressed in pichia yeast organelle, gene, derivative fusion albumen and preparation method thereof
02/28/2007CN1920014A Phosphokinase PKD2 and application thereof
02/28/2007CN1920003A Novel vibrionaceae vibrio bacterial strain and application thereof
02/28/2007CN1920002A Novel vibrionaceae vibrio bacterial strain and application thereof
02/28/2007CN1302113C Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
02/28/2007CN1302110C Paddy rice Osfad 8 coded sequence and its application
02/28/2007CN1302106C Subtilase enzymes of the I-S1 I-S2 sub-groups having an additional amino acid residue in an active site loop region
02/28/2007CN1302105C High-activity cellulase and its preparation method
02/28/2007CN1302104C RNA detection enzyme
02/28/2007CN1302006C Recombinant bovine thrombin
02/28/2007CN1301994C Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus
02/28/2007CA2559848A1 Carnitine palmitoyltransferase-2 (cpt-2) crystals
02/27/2007USRE39497 Storage of materials
02/27/2007US7183458 Isolated nucleic acid sequence; expression cassette of a nucleic acid sequence, a vector and organisms with at least one nucleic acid sequence or expression cassette; unsaturated fatty acids and triglycerides with an increased content of unsaturated fatty acids
02/27/2007US7183457 Isolated polynuoleotide with a nucleotide sequence encoding a polypeptide of an Mlo protein and a complement of the nucleotide sequence; nucleic acid fragments encoding disease resistance genes in plants and seed
02/27/2007US7183403 Genes for heat resistant enzymes of amino acid biosynthetic pathway derived from thermophilic coryneform bacteria
02/27/2007US7183375 Invention relates to peptide sequence which inhibits cleavage of calcineurin subunit A by calpain; cell death suppressant targeting the mechanism of the long term activation of calcineurin but not the calcineurin activation through the transient increase of the intracellular concentration of calcium
02/27/2007US7183256 Polypeptide comprising a portion of carboxy terminal of tissue inhibitor of metalloprotease (TIMP) for use as an inhibitor of endothelial growth factor (VEGF) activities and angiogenesis; treatment and preventative of cell proliferative disorders
02/27/2007US7183110 Antibody immunoreactive with a 5-enolpyruvylshikimate-3-phosphate synthase
02/27/2007US7183107 Enhanced replication of HCV RNA
02/27/2007US7183101 NCC2705—the genome of a bifidobacterium
02/27/2007US7183100 Mitigating virulence of mucoid bacteria via exposure to enzyme inhibitors; bactericides and controlling propagation of exopolysaccharide biofilms
02/27/2007US7183094 Detoxification using amylase; drug screening analysis
02/27/2007US7183093 Comprises hydrolase for treating textiles, degrading plant biomass and fracturing subterranean formations
02/27/2007US7183092 modified luciferase proteins which are more resistant to inhibition by test chemicals than wild type luciferase
02/27/2007US7183091 Sulfite reductase, the process for producing the same and the use thereof
02/27/2007US7183090 Laccase enzyme and the gene encoding the enzyme
02/27/2007US7183087 transformed E. coli comprises a polyhydroxyalkanoate (PHA) synthase gene of Pseudomonas species and lacks a functional fadB gene
02/27/2007US7183082 in vitro and in vivo; involves incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics
02/27/2007US7183071 Anthrax lethal factor is a MAPK kinase protease
02/27/2007US7183070 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders
02/27/2007US7183058 obtaining a biological sample from the domesticated cat and detecting a nucleic acid sequence indicative of a mutation associated with the Siamese phenotype in the domestic cat
02/27/2007US7182945 End group acylation; genetic engineering; rheumatic diseases, respiratory system disorders
02/27/2007CA2174115C Alpha-1,4-glucan lyase from a fungus infected algae, its purification, gene cloning and expression in microorganisms
02/22/2007WO2007022475A1 Fas binding antibodies
02/22/2007WO2007022455A2 Ubiquitin specific enzymes of family herpesviridae
02/22/2007WO2007022231A1 Method to remove bisufite by-products from enzyme compositions
02/22/2007WO2007022045A2 Mutant reverse transcriptase and methods of use
02/22/2007WO2007022009A2 Materials and methods to increase peptide chain expression
02/22/2007WO2007020993A1 Acetohydroxy-acid reductoisomerase gene and use thereof
02/22/2007WO2007020989A1 Sulfate adenyltransferase gene and use thereof
02/22/2007WO2007020428A1 Novel peroxidases and uses
02/22/2007WO2007020291A1 Improving transglutaminase substrate specificity
02/22/2007WO2007020290A1 Transglutaminase variants with improved specificity
02/22/2007WO2007020223A1 Use of matrix metalloproteinases, mutated and not mutated, for the preparation of pharmaceutical compositions, and mutated metalloproteinases with increased stability
02/22/2007WO2007019949A1 Fusion proteins between plant cell-wall degrading enzymes, and their uses
02/22/2007WO2007019859A2 Polypeptides of strain bacillus sp. p203
02/22/2007WO2007019858A2 Subtilases
02/22/2007WO2007019634A1 Arachnocampa luciferases
02/22/2007WO2006134320A3 Glycosyltransferase activity
02/22/2007WO2006133166A3 Nucleic acid molecules encoding sucrose synthase-like polypeptides and methods of use
02/22/2007WO2006128668A3 Coagulation factor x polypeptides with modified activation properties
02/22/2007WO2006120579A3 Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease
02/22/2007WO2006102559A3 Drought-resistant plants
02/22/2007WO2006089206A3 Methods to enhance carbon monoxide dehydrogenase activity and uses thereof
02/22/2007WO2006063302A3 Variants of glycogen synthase kinase 3 and uses thereof
02/22/2007WO2006063055A3 Enzyme conjugates for use as detoxifying agents
02/22/2007WO2006008653A9 Lipolytic enzyme uses thereof in the food industry
02/22/2007WO2005089295A3 WAVE ENERGY CONVERTERS (WECs) WITH VELOCITY MULTIPLICATION
02/22/2007WO2005079463A3 Fructoseamine 3 kinase and the formation of collagen and elastin
02/22/2007WO2005054483A3 Enhanced expression
02/22/2007WO2003089570A3 CRYSTALS AND STRUCTURES OF CMP-KDO SYNTHETASE KdoPS or CKS
02/22/2007US20070044174 Vanillin production
02/22/2007US20070043209 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides
02/22/2007US20070043018 2"-Hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food
02/22/2007US20070042980 Gp131: methods and compositions for treating cancer
02/22/2007US20070042946 Peptide inhibitors of thrombin as potent anticoagulants
02/22/2007US20070042945 Nouvelles compositions et methods de traitement du psoriasis
02/22/2007US20070042500 Direct observation of molecular modifications in biological test systems by measuring flourescence lifetime
02/22/2007US20070042485 Modified TRAP protein for producing nano-scale electrical devices, and a method for producing such a protein
02/22/2007US20070042484 Method to remove bisulfite by-products from enzyme compositions
02/22/2007US20070042481 Preparing acetic acid, lactic acid or ethanol by culturing the lactic acid- or ethanol-producing microorganism transformed with the fdhD and/or fdhE gene; and recovering acetic acid, lactic acid or ethanol from the microbial culture broth
02/22/2007US20070042477 Recombinant vector and microorganism; preparing succinic acid using the transformed microorganism; having the activity of converting malate to fumarate
02/22/2007US20070042476 nucleotide sequence encoding a malic enzyme B having the activity of converting pyruvic acid or pyruvate to malic acid or malate, or vice versa, a recombinant vector containing the gene, a microorganism transformed with recombinant vector, and preparing succinic acid using the transformed microorganism
02/22/2007US20070042475 Method for the enzymatic production of chiral 1-acylated 1,2-diols
02/22/2007US20070042468 Interferon-like protein zcyto21
02/22/2007US20070042467 NIMA interacting proteins
02/22/2007US20070042464 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
02/22/2007US20070042463 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereof
02/22/2007US20070042461 Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
02/22/2007US20070042459 Industrially producing dipeptides easily and inexpensively without going through a complex synthesis
02/22/2007US20070042457 Process for producing penicillin
02/22/2007US20070042451 Glycine decarboxylase complex as a herbicidal target
02/22/2007US20070042435 Assays for sensory modulators using a sensory cell specific G-protein beta subunit
02/22/2007US20070042415 Anti-fused antibodies